Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
https://fintel.io/so/us/vktx
Tutes hold almost 54%
Galt patients story :
http://markanehornibrook.blogspot.com/?m=1
That’s right ! 17% better on hard to treat patients than Keytruda alone on first-time patients. Plus Fewersteins friends shorting every day. How could there be much of a pop ? There could be higher volume, a la Viking.
After that good news this morning, we might be LOWER in the first hour ?? How odd.
No, wasn’t suggesting that. Just jaw-dropping.
For those who are bearish, what lessons from HMNY apply here ? And for those who are bullish, what lessons from Amzn, MSFT, nvda, whoever, apply here ?
It went down 60 points in a minute, then up 70 points in a minute a while later ? Gaaahh !
This went from 300 to 150 in less than an hour ?? Glad I’m on the sidelines.
The latest Tulip being Tilray and other medical marijuana stocks. Dang !
Thank you. Why did they design a trial that way ? Time is money and another trial costs a lot of both.
What about the lack of biopsies ? Might that require another phase 2 and why not ? Some people raise this issue, and I want to understand why I shouldn’t be concerned.
Thanks, T0m. I will be adding a little more before November. But what to sell ? Maybe Galt or Viking will be bought out.
But the resistance line is now set. And since Viking more than doubled this morning, I might sell some and redeploy at CYDY. But, I’m gonna see how far Lagertha goes in the coming days and/or weeks. (my name for VKTX ... she’s hot)
T0m, am I correct in saying there is an ascending channel since July ? Or is it too soon to tell ?
Again, “several weeks”. Not much difference, but some.
Thanks. To be honest, I was stupidly long CYDY this summer. 100%. Nothing else, and I don’t want to go back to that. I just hope galt releases cancer data and gets a nice pop from that. I hope to be able to double or triple my # of shares.
I was so distraught over the extra trial (and wondering if the Prostagene deal would fall through) that this for whatever reason, didn’t register. Thank you, I should buy some CYDY back before the deal closes in the next several weeks.
No, I meant for the same indication.
Say whuuuutt ? $750 Mill ?
What all yet does FDA need to approve this test ?
A long delay and large extra expenses was shrugged off ? I’m stunned
A diagnostic test still needs to be reviewed by the FDA. Does it have a PMA or a 510(k) ?
Couldn’t this help men also, say after a prostate-ectomy ?
But in the nearly 3 years I’ve held this stock, the timelines have been pushed out ... about 3 years. It gets sooo old. Time is money. Lost time is lost money. There’s other 10-baggers out there, folks ! Ones that actually have brokerages and mutual funds investing in them. CYDY Financing issues just might be over in or shortly after November; I really hope so and expect *some* thing positive. Good luck to you all !!
Friday is a very low volume day normally, so whatever reaction there is to the conference call would be magnified somewhat.
I heard delays. A slight delay from during Q1 to the end of Q1 for the CMC portion of BLA. And of course the big delay of an additional trial which will not begin for months and will take likely 9+ months to complete. Yes there are some licensing possibilities and 1 probability. Great ! Yet That can not take place till AFTER the Prostagene deal is completed. Very likely, but not a sure thing.
IMO, the biggest news was much more expense and a large delay in Mono.
I am glad I’ve sold 90% of CYDY in the last few months.
Nader said “several weeks” twice.
Here’s a link to that negative article. CytoDyn's PRO 140: A Potential Victim Of Poor Clinical Development $CYDY
https://seekingalpha.com/article/4206087
It is a complement
Thank you amatuer, for discouraging me out of most of my CYDY, and for encouraging me to diversify. Galt is a great company to invest.
I suppose the company has to be taken seriously before a r/s could work. When announcing PE was met and the market fails to react to that .... “hey lemme tell ya, I don get no respect. “. What can change that ... a world renowned cancer researcher ? You would think. that ought to be finalized in Nov.
Great post, Grip !
I think it is Optimism regarding the upcoming conference call.
I still have enough to pay the mortgage at $10/ share.
I am 3 years patient, but that’s not enough.
I sell some shares; and CYDY pops 20%. Cause and effect, apparently. You’re welcome !
There’s more than one was to skin a prostate cancer, and in his expert opinion he chose to work with ccr5 inhibitor over a galectin inhibitor. That’s good.
No. $12 K of stock purchase makes an .... 8% change ? Seen that sort of thing on the downside, too.
Dr Pestell chose CYDY over GALT. https://www.businesswire.com/news/home/20180208005344/en/Modified-Citrus-Pectin-Shows-Significant-Benefits-Biochemically